期刊文献+

TRIO的扩增和高表达与膀胱肿瘤细胞的快速增殖有关

TRIO amplification and over-expression is associated with rapid tumor cell proliferation in urinary bladder cancer
下载PDF
导出
摘要 目的TRIO基因位于染色体5p扩增区、编码1种在细胞周期调节中起主导作用的蛋白,本研究旨在了解TRIO的扩增和表达是否与膀胱肿瘤细胞的快速增殖有关。方法Ki67标记染色(Ki67LI)、荧光原位杂交(FISH)和定量PCR法(LightCyclerTMPCR)被用于研究。结果TRIO基因扩增与膀胱肿瘤细胞的快速生长相关(P<0.0001)。膀胱肿瘤分化越差、临床分期越高,Ki67LI与TRIO基因扩增数目均越高。含2317例组织微阵列FISH结果显现TRIO扩增仅见于1.8%早期膀胱肿瘤(pTa)(9例/499例),而在膀胱癌(pT1-4)高达12.8%(62例/485例)。定量PCR法进一步证实TRIO在显示5p扩增的膀胱癌组织高表达。结论TRIO扩增与膀胱肿瘤细胞的快速增殖有关,TRIO扩增和高表达可能在膀胱癌的发展过程中发挥重要作用。 Objective:TRIO gene located to human chromosome bands 5p encodes a protein with a putative role in cell-cycle regulation. This study aims to find out whether the amplification and expression of TRIO is correlated to rapid proliferation of bladder cancer cells. Methods: Ki 67 labeling index(Ki-67LI), fluorescence in situ hybridization(FISH), and quantitative PCR (LightCycler TMPCR) were used. Results:TRIO amplification was strongly associated with rapid proliferation of bladder cancer cells(P〈0.0001). High tumor grade and low tumor differentiation was accompanied with elevated Ki67 1.1 and TRIO amplification. Tissue microarray FISH results containing 2 317 samples showed that TRIO amplification was observed only in 9 of 499 pTa tumors (1.8%) but 62 of 485 pT1-4 carcinomas (12.8%). Quantitative PCR analysis confirmed that TRIO was over-expressed in 5p-amplified bladder tumors. Conclusion: TRIO amplification was associated with rapid tumor cell proliferation in blad der cancer. TRIO amplification/over-expression has a potential role in bladder cancer progression.
出处 《肿瘤》 CAS CSCD 北大核心 2006年第2期127-130,共4页 Tumor
基金 瑞士国家自然科学基金资助项目(编号:E420663)
关键词 膀胱肿瘤 基因 TRIO 原位杂交 荧光 定量聚核酶链反应 Bladder neoplasms Gene,TRIO In situ hybridization,fluorescence Quantitative polymerase chain reaction
  • 相关文献

参考文献1

二级参考文献19

  • 1FariasEisner R,Teng F,Oliveira M,et al.The influence of tumor grade,distribution,and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery [J].Gynecol Oncol,1994,55(1):108-110.
  • 2van Dam PA,Vergote IB,Lowe DG,et al.Expression of c-erbB-2,c-myc,and c-ras oncoproteins,insulin-like growth factor receptor I,and epidermal growth factor receptor in ovarian carcinoma [J].J Clin Pathol,1994,47(10):914-919.
  • 3Iwamoto H,Fukasawa H,Honda T,et al.HER-2/neu expression in ovaria n clear cell carcinomas [J].Int J Gynecol Cancer,2003,13(1):28-31.
  • 4Hellstrom I,Goodman G,Pullman J,et al.Overexpression of HER-2 in ovarian carcinomas [J].Cancer Res,2001,15; 61(6):2420-2423.
  • 5Modugno F.Ovarian Cancer and High-Risk Women Symposium Presenters.Ovarian cancer and high-risk women implications for prevention,screening,and early detection [J].Gynecol Oncol,2003,91(1):15-31.
  • 6Memarzadeh S,Lee SB,Berek JS,et al.CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer [J].Int J Gynecol Cancer,2003,13(2):120-124.
  • 7Miralles C,Orea M,Espana P,et al.Cancer antigen 125 associated with multiple benign and malignant pathologies [J].Ann Surg Oncol,2003,10(2):150-154.
  • 8Okuda T,Otsuka J,Sekizawa A,et al.p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer [J].Gynecol Oncol,2003,88(3):318-325.
  • 9Kumar A,Knott C,Kuus-Reichel K,et al.BRCA1 partially reverses the transforming activity of the ras oncogene [J].Neoplasia,1999,(5):417-423.
  • 10Moch H,Schraml P,Bubendorf L,et al.High-Throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma [J].Am J Pathol,1999.154 (4):981-986.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部